Profil
Samina Khan occupe actuellement le poste de médecin en chef et de vice-présidente principale de Reata Pharmaceuticals, Inc. Le Dr Khan était auparavant vice-présidente des programmes cardio-rénaux chez Quark Pharmaceuticals, Inc.
Anciens postes connus de Samina Khan
| Sociétés | Poste | Fin |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 26/09/2023 |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Corporate Officer/Principal | 01/04/2017 |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Samina Khan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Health Technology |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















